CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 113 filers reported holding CEMPRA INC in Q4 2014. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $42,000 | -97.2% | 15,000 | -75.4% | 0.00% | -97.8% |
| Q3 2016 | $1,476,000 | +42.7% | 61,000 | -2.7% | 0.09% | +13.8% |
| Q2 2016 | $1,034,000 | -43.8% | 62,694 | -40.3% | 0.08% | 0.0% |
| Q1 2016 | $1,840,000 | -40.9% | 105,000 | +5.0% | 0.08% | -62.6% |
| Q4 2015 | $3,113,000 | -17.8% | 100,000 | -26.5% | 0.21% | +28.1% |
| Q3 2015 | $3,786,000 | -8.9% | 136,000 | +12.4% | 0.17% | +1.8% |
| Q2 2015 | $4,158,000 | +0.1% | 121,000 | 0.0% | 0.16% | -10.9% |
| Q1 2015 | $4,152,000 | +120.7% | 121,000 | +51.2% | 0.18% | +183.1% |
| Q4 2014 | $1,881,000 | +71.6% | 80,000 | -20.0% | 0.06% | +140.7% |
| Q3 2014 | $1,096,000 | -7.1% | 100,000 | -9.1% | 0.03% | +3.8% |
| Q2 2014 | $1,180,000 | +2.2% | 110,000 | +10.0% | 0.03% | +13.0% |
| Q1 2014 | $1,155,000 | +3.6% | 100,000 | +11.1% | 0.02% | -4.2% |
| Q4 2013 | $1,115,000 | -55.9% | 90,000 | -59.1% | 0.02% | -11.1% |
| Q3 2013 | $2,530,000 | +195.9% | 220,000 | +100.0% | 0.03% | +8.0% |
| Q2 2013 | $855,000 | – | 110,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |